Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
By Kamal Choudhury Feb 9 (Reuters) – Privately held Iambic said on Monday it has entered a multi-year…
Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies
The glomerulonephritis market is witnessing steady growth driven by the increasing prevalence of chronic kidney diseases and improved…